New appointment at Cyntellect
This article was originally published in Scrip
Cyntellect, a privately held US-based life sciences company focused on stem cell research, biopharmaceutical production and drug discovery, has appointed Saiid Zarrabian president and chief executive officer. He succeeds Dr Fred Koller, who has assumed the position of chief technology officer. Mr Zarrabian has been consulting with the company and has been acting CEO since March. He has previously served as president and chief operating officer at Synomyx, as COO at Pharmacopeia, and as president and COO of Molecular Simulations.